Alpha-Hydroxyisocaproic Acid
Mechanism of Action +
### Leucine Metabolism and the Formation of HICA
To understand the biochemical role of Alpha-Hydroxyisocaproic Acid (HICA), one must first examine the metabolic pathway of its parent compound, the branched-chain amino acid (BCAA) L-leucine. Leucine is widely recognized as the primary nutritional signal for the activation of the mammalian target of rapamycin complex 1 (mTORC1), the master regulator of muscle protein synthesis (MPS). However, the anti-catabolic effects of leucine—its ability to prevent muscle protein breakdown (MPB)—are largely attributed to its downstream metabolites.
When leucine is ingested, a significant portion is utilized for protein synthesis, but the remainder undergoes catabolism primarily in skeletal muscle. The first step in this pathway is the reversible transamination of leucine by the enzyme branched-chain aminotransferase (BCAT), which transfers the alpha-amino group to alpha-ketoglutarate, forming glutamate and alpha-ketoisocaproate (KIC). KIC is the central metabolic hub for leucine degradation.
From KIC, the pathway diverges. The majority of KIC is irreversibly oxidatively decarboxylated by the branched-chain alpha-keto acid dehydrogenase (BCKDH) complex within the mitochondria, eventually yielding acetyl-CoA and acetoacetate. A small fraction (approximately 5%) of KIC is oxidized in the cytosol by the enzyme KIC dioxygenase to form beta-hydroxy-beta-methylbutyrate (HMB). Finally, another fraction of KIC can be reduced to form Alpha-Hydroxyisocaproic Acid (HICA), also known as leucic acid. This reduction is believed to be catalyzed by enzymes such as lactate dehydrogenase or specific hydroxy acid dehydrogenases, converting the keto group of KIC into a hydroxyl group.
### Anti-Catabolic Mechanisms and Proteolysis Inhibition
While leucine and HMB have been extensively studied, the specific intracellular mechanisms of HICA are less defined but are hypothesized to share overlapping characteristics with its metabolic siblings. The primary mechanism by which HICA is believed to exert its ergogenic effects is through the inhibition of muscle protein breakdown (anti-catabolism) rather than the direct stimulation of muscle protein synthesis.
During periods of intense physical stress, such as high-volume resistance training or exhaustive cardiovascular exercise (e.g., soccer or wrestling), the body enters a catabolic state. This state is characterized by the upregulation of proteolytic pathways, including the ubiquitin-proteasome system, calpains, and matrix metalloproteinases (MMPs). It is theorized that HICA may act as a mild inhibitor of these proteolytic enzymes, particularly metalloproteinases, thereby preserving existing muscle tissue.
Furthermore, HICA may play a role in neutralizing ammonia accumulation during intense exercise. Ammonia is a toxic byproduct of amino acid catabolism and AMP deamination during high-intensity muscle contractions. Elevated ammonia levels contribute to central and peripheral fatigue. By providing a carbon skeleton that can potentially interact with nitrogenous waste, HICA might help buffer ammonia, though this mechanism requires further in vivo validation.
### Modulation of Delayed Onset Muscle Soreness (DOMS)
One of the most clinically noted effects of HICA supplementation is the reduction of Delayed Onset Muscle Soreness (DOMS). DOMS is primarily caused by microtrauma to muscle fibers during eccentric contractions, leading to a localized inflammatory response, edema, and the sensitization of nociceptors (pain receptors).
If HICA successfully blunts the initial proteolytic response to microtrauma, the subsequent inflammatory cascade—mediated by cytokines, prostaglandins, and leukotrienes—may be attenuated. By reducing the magnitude of muscle tissue degradation, HICA indirectly lowers the release of intracellular contents (like creatine kinase and myoglobin) into the extracellular space, which are markers of muscle damage. This attenuation of damage and inflammation translates subjectively to reduced muscle soreness, allowing athletes to maintain higher training volumes and frequencies without being hindered by debilitating DOMS.
### Pharmacokinetics and Bioavailability
Currently, detailed pharmacokinetic profiling of HICA in humans is sparse. However, as a small-chain hydroxy acid, it is highly water-soluble and is expected to be rapidly absorbed from the gastrointestinal tract via passive diffusion and potentially specific monocarboxylate transporters (MCTs). Once in the systemic circulation, it is readily taken up by skeletal muscle tissue.
In clinical trials, HICA is typically administered in divided doses (e.g., 500 mg three times daily). This dosing strategy suggests that HICA, like many amino acid metabolites, likely has a relatively short plasma half-life, necessitating multiple daily intakes to maintain elevated systemic and intramuscular concentrations. It is primarily excreted via the urine, either unchanged or after further hepatic metabolism.
Is HICA safe to use? +
Is HICA effective for athletes? +
What is HICA derived from? +
What is alpha Hydroxyisocaproic acid calcium? +
What is hica and what are the effects of its supplementation for a period of 4 weeks? +
What is the difference between HICA and HMB? +
When should I take HICA? +
Do I need to cycle HICA? +
Can women take HICA? +
Does HICA build muscle? +
Does HICA help with DOMS? +
Is HICA better than Leucine? +
Can I take HICA on rest days? +
Does HICA cause weight gain? +
What foods contain HICA? +
Can I stack HICA with creatine? +
Does HICA interact with medications? +
Is HICA a steroid? +
How long does it take for HICA to work? +
Everything About Alpha-Hydroxyisocaproic Acid Article
## Introduction to HICA (Leucic Acid)
If you have spent any time researching sports nutrition supplements, you are likely familiar with the branched-chain amino acids (BCAAs), and specifically, the powerhouse amino acid L-Leucine. Leucine is famous for being the primary trigger for muscle protein synthesis—the process by which the body builds new muscle tissue. However, what happens to leucine after it enters the body is just as fascinating. As leucine is metabolized, it breaks down into several downstream compounds. One of these specific metabolites is Alpha-Hydroxyisocaproic Acid, commonly known as HICA or Leucic Acid.
Much like its more famous sibling, HMB (Beta-Hydroxy Beta-Methylbutyrate), HICA is an anti-catabolic agent. This means that rather than directly building new muscle, its primary job is to protect the muscle you already have from being broken down during intense physical stress. In this comprehensive guide, we will explore the biochemistry of HICA, what the clinical studies reveal, and how you can use it to reduce soreness and improve your recovery.
## The Science of Leucine Metabolites
To understand HICA, you must understand leucine. All the protein we eat is broken down into various amino acids. Leucine is an essential amino acid, meaning the body cannot produce it on its own; it must be acquired through diet or supplementation.
When you consume leucine, the body uses a large portion of it to signal the mTOR pathway, which turns on muscle building. However, the leucine that isn't used for synthesis is metabolized. It is first converted into a compound called alpha-ketoisocaproate (KIC). From KIC, the metabolic pathway splits. A small percentage is converted into HMB, while another fraction is converted into HICA.
Because HICA makes up only a small percentage of the leucine we eat, it is nearly impossible to get clinical doses of HICA simply by eating high-protein foods or taking standard BCAA supplements. To experience the specific benefits of HICA, it must be supplemented directly.
## How HICA Works in the Body
With leucine acting as the main stimulus for positive muscle anabolism (growth), researchers hypothesized that its metabolites might be responsible for preventing muscle catabolism (breakdown).
During intense training—whether it's heavy weightlifting, sprinting, or playing a demanding sport like soccer—your muscle fibers experience microtrauma. This trauma is necessary for growth, but it also triggers a catabolic response where muscle proteins are degraded. HICA is believed to inhibit specific enzymes, such as metalloproteinases, that are responsible for this muscle breakdown.
By blunting the degradation of muscle tissue, HICA shifts the overall net protein balance in a positive direction. If your body is building muscle at a normal rate, but breaking down less muscle than usual, the net result is an increase in lean mass. Furthermore, by reducing the amount of muscle damage that occurs during a workout, HICA significantly mitigates the inflammatory response that causes Delayed Onset Muscle Soreness (DOMS).
## Clinical Evidence and Real-World Results
The most prominent study on HICA was published in 2010 by Dr. Antti Mero and colleagues. The study focused on a team of highly conditioned, competitive soccer players.
The athletes were divided into two groups: a placebo group and a HICA group. The HICA group consumed 1,500 mg of HICA daily, split into three 500 mg doses, for four weeks. The placebo group consumed maltodextrin. Both groups continued their rigorous routines, which included multiple cardiovascular soccer practices and two heavy weight training sessions per week. Their diets were controlled, with protein intake hovering around 1.6 grams per kilogram of body weight (a moderate amount, but lower than typical bodybuilding standards).
At the end of the four-week trial, the results were highly compelling. The athletes taking HICA gained an average of 0.4 kg (almost 1 pound) of lean muscle mass in their lower body. In contrast, the placebo group actually *lost* 0.15 kg of lean mass due to the catabolic nature of their intense training. Furthermore, the HICA group reported significantly lower levels of Delayed Onset Muscle Soreness (DOMS) compared to the placebo group.
This study highlights HICA's exact use-case: it is an insurance policy against muscle loss during periods of extreme physical exertion, and a powerful tool for reducing soreness.
## HICA vs. HMB vs. Leucine
A common question among athletes is whether they should take HICA, HMB, or just stick to Leucine.
* **Leucine:** The king of muscle protein synthesis. If your goal is to trigger the building of new muscle, Leucine (or a full spectrum EAA supplement) is mandatory. However, Leucine alone is not highly efficient at preventing muscle breakdown. * **HMB:** The most heavily researched leucine metabolite. HMB has dozens of studies supporting its anti-catabolic effects, particularly in untrained individuals, the elderly, or athletes in a severe caloric deficit. * **HICA:** Less researched than HMB, but highly regarded in anecdotal bodybuilding circles. Some athletes who classify themselves as "non-responders" to HMB report excellent results with HICA regarding DOMS reduction.
Ultimately, HICA should not replace Leucine. Instead, it should be viewed as a complementary supplement. You take Leucine to build, and HICA to preserve.
## Dosage and Optimal Timing
Based on the clinical data, the optimal dosage for HICA is **1,500 mg (1.5 grams) per day**.
Because HICA is metabolized relatively quickly, it is highly recommended to split this dosage up throughout the day. The standard protocol is to take **500 mg, three times daily**.
* **Timing:** Taking one of your 500 mg doses roughly 30 minutes prior to your workout, or sipping it during your workout, is ideal for getting the compound into your bloodstream when muscle damage is actively occurring. The other two doses should be taken with meals. * **Cycling:** There is no need to cycle HICA. It is a natural amino acid metabolite and does not downregulate any of the body's natural receptors or hormone production.
## Safety and Side Effects
HICA is considered highly safe for human consumption. In the clinical trials conducted thus far, no significant adverse side effects have been reported. It does not negatively impact liver or kidney enzymes, nor does it alter hormonal profiles.
Because it is simply a byproduct of normal protein digestion, the body is well-equipped to process it. However, as with all dietary supplements, pregnant or nursing women should avoid use due to a lack of specific safety data in those populations. Individuals with rare genetic disorders affecting BCAA metabolism (such as Maple Syrup Urine Disease) must avoid HICA entirely.